Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for HLBBF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 8.061B
March 31, 2026 8.065B
December 31, 2025 8.493B
September 30, 2025 8.373B
June 30, 2025 8.151B
March 31, 2025 7.850B
December 31, 2024 8.196B
September 30, 2024 5.916B
June 30, 2024 5.617B
March 31, 2024 5.481B
December 31, 2023 5.734B
September 30, 2023 5.349B
June 30, 2023 5.457B
March 31, 2023 5.341B
December 31, 2022 5.591B
September 30, 2022 5.179B
June 30, 2022 5.240B
March 31, 2022 5.246B
December 31, 2021 5.605B
September 30, 2021 5.474B
June 30, 2021 5.428B
March 31, 2021 5.446B
December 31, 2020 6.225B
September 30, 2020 5.772B
June 30, 2020 5.606B
Date Value
March 31, 2020 5.446B
December 31, 2019 6.089B
September 30, 2019 3.427B
June 30, 2019 3.369B
March 31, 2019 3.267B
December 31, 2018 3.525B
September 30, 2018 3.489B
June 30, 2018 3.401B
March 31, 2018 3.259B
December 31, 2017 3.186B
September 30, 2017 3.218B
June 30, 2017 2.945B
March 31, 2017 2.974B
December 31, 2016 2.867B
September 30, 2016 3.023B
June 30, 2016 3.031B
March 31, 2016 3.153B
December 31, 2015 3.166B
September 30, 2015 3.319B
June 30, 2015 3.099B
March 31, 2015 3.814B
December 31, 2014 4.166B
September 30, 2014 4.230B
June 30, 2014 4.215B
March 31, 2014 4.330B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Novo Nordisk A/S 91.00B
ALK-Abello A/S 1.487B
AstraZeneca PLC 114.02B
ANI Pharmaceuticals, Inc. 1.494B
Corcept Therapeutics, Inc. 888.70M

Total Assets (Quarterly) Related Metrics